Advertisement
U.S. Markets open in 1 hr 19 mins

ORIC Pharmaceuticals, Inc. (ORIC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
10.30+0.62 (+6.40%)
At close: 04:00PM EST
10.10 -0.20 (-1.94%)
After hours: 06:12PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 726.59M
Enterprise Value 442.95M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.40
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.13

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 316.65
52 Week Low 35.85
50-Day Moving Average 39.71
200-Day Moving Average 310.19

Share Statistics

Avg Vol (3 month) 3464.13k
Avg Vol (10 day) 3551.31k
Shares Outstanding 570.54M
Implied Shares Outstanding 6N/A
Float 842.72M
% Held by Insiders 19.13%
% Held by Institutions 199.12%
Shares Short (Oct 15, 2024) 412M
Short Ratio (Oct 15, 2024) 425.72
Short % of Float (Oct 15, 2024) 417.27%
Short % of Shares Outstanding (Oct 15, 2024) 417.01%
Shares Short (prior month Sep 13, 2024) 412.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.20%
Return on Equity (ttm)-38.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -124.06M
Net Income Avi to Common (ttm)-110.78M
Diluted EPS (ttm)-1.76
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)286.41M
Total Cash Per Share (mrq)4.06
Total Debt (mrq)9.74M
Total Debt/Equity (mrq)3.22
Current Ratio (mrq)15.08
Book Value Per Share (mrq)4.47

Cash Flow Statement

Operating Cash Flow (ttm)-99.73M
Levered Free Cash Flow (ttm)-59.14M